Daniel Lipka

@dblipka.bsky.social

Physician Scientist at DKFZ & NCT Heidelberg studying 🩸🧬 #epigenomics #DNAmethylation #singleCell #precisiononcology #JMML www.translational-cancer-epigenomics.de

Neue Erkenntnisse zu akuten Leukämien: Bestimmte Mutationen liefern Ansatzpunkte für gezieltere Therapien Forschende des NCT Heidelberg und des Deutschen Krebsforschungszentrums (@dkfz.bsky.social) haben erstmals systematisch ermittelt, wie bestimmte Mutationen akute myeloische Leukämien fördern.

Bild

I’m excited to share that my PhD paper is officially out now in @bloodjournals.hematology.org Check out our discovery of how mutant IDH1 but not IDH2 leads to a lineage-specific differentiation block via epigenetic repression of lineage programs! 📄 Paper link below: 👇 doi.org/10.1182/bloo...

Daniel Lipka@dblipka.bsky.social · 2mo ago

🧵 NEW PAPER in @bloodjournal.bsky.social! Why do IDH1 mutations almost exclusively drive myeloid #leukemia, while IDH2 mutations occur in both myeloid AND lymphoid cancers? 🤔 #AML #Epigenetics Despite sharing the same biochemical mechanism, they are NOT equivalent. Here's what we found 👇